EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Inhibiting Hmox1 in Sepsis‐Induced Lung Injury: A Molecular Mechanism Study

Qingying Li, Xu Yu, Renjie Yu, Xinge Shi, Yibin Lu iD

Journal of Biochemical and Molecular Toxicology · 2025-02 · 39 (2)

DOI: 10.1002/jbt.70134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 17.02.2025. Verfasst von Qingying Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Xinyang Central Hospital, Xinyang, China. Hauptthemen laut MEDLINE: Sepsis, Heme Oxygenase-1, Lung Injury, Enzyme Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Key R&D and Promotion Special Project of Xinyang City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis induces severe multiorgan dysfunction, with the lungs being particularly susceptible to damage. This study reveals that Hmox1 inhibitors effectively activate the FSP1/CoQ10/NADPH pathway, significantly enhancing autophagic activity while suppressing ferroptosis in alveolar epithelial cells, thereby alleviating lung injury in septic mice. To identify key gene modules and regulatory factors associated with sepsis‐induced lung injury, we analyzed public transcriptomic data, including bulk RNA‐seq datasets (GSE236391 and GSE263867) and a single‐cell RNA‐seq (scRNA‐seq) data set (GSE207651). In vitro experiments were conducted using an LPS‐induced alveolar epithelial cell injury model to evaluate the effects of Hmox1 inhibitors on cell viability, autophagy markers (LC3‐II/LC3‐I and p62), ROS levels, and intracellular iron content. Transmission electron microscopy was used to observe mitochondrial structural changes. In vivo, a cecal ligation and puncture (CLP)‐induced sepsis mouse model was established to assess the therapeutic effects of Hmox1 inhibitors. This included evaluating survival rates, lung histopathological scores, lung wet‐to‐dry weight ratios, myeloperoxidase (MPO) activity, inflammatory cytokine levels, and changes in autophagy and ferroptosis markers. The results demonstrated that Hmox1 inhibitors effectively mitigate lung injury by modulating the autophagy‐ferroptosis pathway, highlighting their potential as a therapeutic strategy for sepsis‐induced lung damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisHeme Oxygenase-1Lung InjuryEnzyme InhibitorsAnimalsMiceAutophagyFerroptosisMaleMice, Inbred C57BLHumansDisease Models, AnimalMembrane Proteins

Stichwörter der Autor:innen

FSP1/CoQ10/NADPH pathwayautophagy‐ferroptosisheme oxygenase‐1 inhibitorlung injurymouse modelsepsis

Substanzen

Heme Oxygenase-1Hmox1 protein, mouseEnzyme InhibitorsMembrane Proteins

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Xinyang Central Hospital, Xinyang, China.

ORCID-Profile: Yibin Lu

Förderung

  • Key R&D and Promotion Special Project of Xinyang City

Zitieren

APA

Li, Q., Yu, X., Yu, R., Shi, X., & Lu, Y. (2025). Therapeutic Potential of Inhibiting Hmox1 in Sepsis‐Induced Lung Injury: A Molecular Mechanism Study. Journal of Biochemical and Molecular Toxicology, 39(2). https://doi.org/10.1002/jbt.70134

Vancouver

Li Q, Yu X, Yu R, Shi X, Lu Y. Therapeutic Potential of Inhibiting Hmox1 in Sepsis‐Induced Lung Injury: A Molecular Mechanism Study. Journal of Biochemical and Molecular Toxicology. 2025;39(2). doi:10.1002/jbt.70134

BibTeX
@article{Li2025,
  author = {Li, Qingying and Yu, Xu and Yu, Renjie and Shi, Xinge and Lu, Yibin},
  title = {Therapeutic Potential of Inhibiting Hmox1 in Sepsis‐Induced Lung Injury: A Molecular Mechanism Study},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  volume = {39},
  number = {2},
  doi = {10.1002/jbt.70134}
}
Kostenlos starten →